PAA Cleansing Notice 04/09/23 download Created with Sketch. 211.39KB Share PAA Application for quotation of securities - PAA 04/09/23 download Created with Sketch. 24.48KB Share PAA Appendix 4G & Corporate Governance Statement 31/08/23 download Created with Sketch. 588.23KB Share PAA Appendix 4E & Full Year Statutory Accounts 31/08/23 PRICE SENSITIVE download Created with Sketch. 1.21MB Share PAA Chief Executive Officer Appointment 28/08/23 PRICE SENSITIVE download Created with Sketch. 209.6KB Share PAA Release of Restricted Securities from Escrow 25/08/23 download Created with Sketch. 183.72KB Share PAA Additional Phase 1 data suggest MPL may inhibit MND 22/08/23 PRICE SENSITIVE download Created with Sketch. 351.67KB Share PAA Trading Halt 17/08/23 PRICE SENSITIVE download Created with Sketch. 552.24KB Share PAA Cohort 3 Pharmacokinetics in MND Patients Completed 09/08/23 PRICE SENSITIVE download Created with Sketch. 305.56KB Share PAA Epichem enters voluntary liquidation 01/08/23 PRICE SENSITIVE download Created with Sketch. 149.19KB Share PAA Appendix 4C and Quarterly Update 31/07/23 PRICE SENSITIVE download Created with Sketch. 1.58MB Share PAA MND Trial Successfully Completes 3rd Patient Cohort 28/07/23 PRICE SENSITIVE download Created with Sketch. 183.55KB Share PAA Canine Trial Update 13/07/23 PRICE SENSITIVE download Created with Sketch. 1.23MB Share PAA Results show MPL suppresses biomarkers associated with MND 11/07/23 PRICE SENSITIVE download Created with Sketch. 248.2KB Share PAA Trading Halt 10/07/23 PRICE SENSITIVE download Created with Sketch. 575.59KB Share PAA Change of Director's Interest Notice x 3 07/07/23 download Created with Sketch. 230.77KB Share PAA s708A(5)(e) notice 07/07/23 download Created with Sketch. 204.09KB Share PAA Notification of cessation of securities - PAA 07/07/23 download Created with Sketch. 21.57KB Share PAA Notification regarding unquoted securities - PAA 07/07/23 download Created with Sketch. 25.64KB Share PAA Application for quotation of securities - PAA 07/07/23 download Created with Sketch. 24.77KB Share PAA Louie the Beagle surpasses one year on MPL 06/07/23 PRICE SENSITIVE download Created with Sketch. 440.49KB Share PAA MND Biomarkers and Pharmacodynamics Results 04/07/23 PRICE SENSITIVE download Created with Sketch. 341.97KB Share PAA Results of General Meeting 30/06/23 download Created with Sketch. 348.02KB Share PAA Trading Halt 30/06/23 PRICE SENSITIVE download Created with Sketch. 217.47KB Share PAA General Meeting - Chairman Script 30/06/23 download Created with Sketch. 255.48KB Share PAA Motor Neurone Disease Phase 1/2 Clinical Trial Update 27/06/23 PRICE SENSITIVE download Created with Sketch. 209.8KB Share PAA Commencement of Cohort 3 in Phase 1/2 MND Trial 09/06/23 download Created with Sketch. 203.06KB Share PAA PharmAust MND Trial Interim Analysis PK Outcomes 07/06/23 PRICE SENSITIVE download Created with Sketch. 364.64KB Share PAA Trading Halt 05/06/23 PRICE SENSITIVE download Created with Sketch. 578.64KB Share PAA Notice of General Meeting/Proxy Form 26/05/23 download Created with Sketch. 544.76KB Share PAA Motor Neurone Disease Clinical Trial Update 22/05/23 PRICE SENSITIVE download Created with Sketch. 206.61KB Share PAA Securities issued under LR7.1 & LR7.1A 16/05/23 download Created with Sketch. 193.78KB Share PAA Progress update on Phase 1/2 MND interim analysis 16/05/23 PRICE SENSITIVE download Created with Sketch. 258.68KB Share PAA Application for quotation of securities - PAA 11/05/23 download Created with Sketch. 27KB Share PAA Cancel - Notification regarding unquoted securities - PAA 11/05/23 download Created with Sketch. 27.12KB Share PAA Notification regarding unquoted securities - PAA 11/05/23 download Created with Sketch. 27.56KB Share PAA Terms & Conditions of Unlisted Options 11/05/23 download Created with Sketch. 94.11KB Share PAA Appendix 3Y 11/05/23 download Created with Sketch. 182.68KB Share PAA Section 708(5) Notice 11/05/23 download Created with Sketch. 203.85KB Share PAA Notification regarding unquoted securities - PAA 11/05/23 download Created with Sketch. 27.39KB Share PAA Notification regarding unquoted securities - PAA 11/05/23 download Created with Sketch. 27.22KB Share PAA Application for quotation of securities - PAA 11/05/23 download Created with Sketch. 24.55KB Share PAA Independent tests show MPL retains long-term shelf-life 10/05/23 PRICE SENSITIVE download Created with Sketch. 274.33KB Share PAA MPL has anti-cancer effects across multiple cancer types 09/05/23 PRICE SENSITIVE download Created with Sketch. 655.11KB Share PAA Proposed issue of securities - PAA 03/05/23 download Created with Sketch. 28.01KB Share PAA PharmAust Raises $2.5m via Placement 03/05/23 PRICE SENSITIVE download Created with Sketch. 205.33KB Share PAA Appendix 4C and Quarterly Update 28/04/23 PRICE SENSITIVE download Created with Sketch. 1.24MB Share PAA Trading Halt 28/04/23 PRICE SENSITIVE download Created with Sketch. 577.21KB Share PAA MND Trial Successfully Completes Second Patient Cohort 28/04/23 PRICE SENSITIVE download Created with Sketch. 231.89KB Share PAA Canine Trial Update 21/04/23 PRICE SENSITIVE download Created with Sketch. 1.42MB Share PAA Arrival of additional MPL tablets 17/04/23 PRICE SENSITIVE download Created with Sketch. 227.21KB Share PAA PharmAust launches international CEO search 13/04/23 PRICE SENSITIVE download Created with Sketch. 234.9KB Share PAA MND Trial Completes Enrolment of Cohort 2 30/03/23 PRICE SENSITIVE download Created with Sketch. 209.15KB Share PAA Stable Patient in MND trial reaches 6-months on MPL 28/03/23 PRICE SENSITIVE download Created with Sketch. 200.46KB Share PAA PharmAust Investor Webinar Presentation 16/03/23 download Created with Sketch. 3.61MB Share PAA AOG Energy Conference Presentation 15/03/23 download Created with Sketch. 2.79MB Share PAA Investor Webinar 14/03/23 download Created with Sketch. 194.38KB Share PAA Correction to Appendix 3Y 13/03/23 download Created with Sketch. 183.17KB Share PAA Change of Director's Interest Notice 13/03/23 download Created with Sketch. 183.22KB Share PAA Canine Cancer Trial Update 07/03/23 PRICE SENSITIVE download Created with Sketch. 351.24KB Share PAA Interim analysis recommended in MND trial 02/03/23 PRICE SENSITIVE download Created with Sketch. 253.45KB Share PAA European Patent relating to MPL Combinations in Cancer 28/02/23 PRICE SENSITIVE download Created with Sketch. 202KB Share PAA Appendix 4D & Half Year Report 27/02/23 PRICE SENSITIVE download Created with Sketch. 464.1KB Share PAA First Patient of Cohort 2 Dosed in MND Trial 20/02/23 PRICE SENSITIVE download Created with Sketch. 263.75KB Share PAA PharmAust canine trial update 10/02/23 PRICE SENSITIVE download Created with Sketch. 2.39MB Share PAA Appendix 4C and Quarterly Update 30/01/23 PRICE SENSITIVE download Created with Sketch. 2.77MB Share PAA PharmAust Progresses to Elevated Doses in MND Patients 20/01/23 PRICE SENSITIVE download Created with Sketch. 198.44KB Share PAA Change of Director's Interest Notice 10/01/23 download Created with Sketch. 183.37KB Share PAA MND Trial Successfully Completes First Patient Cohort 06/01/23 PRICE SENSITIVE download Created with Sketch. 325.82KB Share PAA PharmAust Canine Trial Update clarification 20/12/22 PRICE SENSITIVE download Created with Sketch. 3.29MB Share PAA PharmAust Canine Trial Update 20/12/22 PRICE SENSITIVE download Created with Sketch. 3.2MB Share PAA PharmAust Receives R&D Tax Incentive Refund 12/12/22 PRICE SENSITIVE download Created with Sketch. 185.99KB Share PAA MND Trial Completes Enrolment of First Patient Cohort 02/12/22 PRICE SENSITIVE download Created with Sketch. 252.5KB Share PAA Results of Annual General Meeting 11/11/22 download Created with Sketch. 467.34KB Share PAA AGM Presentation 10/11/22 download Created with Sketch. 2.33MB Share PAA Epichem webinar presentation 04/11/22 download Created with Sketch. 1.21MB Share PAA DNDi contract extension for PharmAust subsidiary Epichem 03/11/22 PRICE SENSITIVE download Created with Sketch. 250.21KB Share PAA Investor Webinar 01/11/22 download Created with Sketch. 103.73KB Share PAA Appendix 4C and Quarterly Update 31/10/22 PRICE SENSITIVE download Created with Sketch. 2.31MB Share PAA First Patient Dosed in MND Phase 1/2 Trial 03/10/22 PRICE SENSITIVE download Created with Sketch. 213.96KB Share PAA Notice of Annual General Meeting/Proxy Form 30/09/22 download Created with Sketch. 462.49KB Share PAA Change of Director's Interest Notice 13/09/22 download Created with Sketch. 182.88KB Share PAA First Patient in US Canine Cancer Trials Begins Treatment 07/09/22 PRICE SENSITIVE download Created with Sketch. 209.08KB Share PAA Appendix 4G & Corporate Governance Statement 26/08/22 download Created with Sketch. 542.46KB Share PAA Appendix 4E & Full Year Statutory Accounts 26/08/22 PRICE SENSITIVE download Created with Sketch. 1.5MB Share PAA Update on PharmAust Canine Cancer Trials 17/08/22 PRICE SENSITIVE download Created with Sketch. 375.4KB Share PAA Appendix 4C and Quarterly Update 20/07/22 PRICE SENSITIVE download Created with Sketch. 634.05KB Share PAA Notification of cessation of securities - PAA 30/06/22 download Created with Sketch. 21.48KB Share PAA Science Week Conference Presentation 24/06/22 download Created with Sketch. 704.25KB Share PAA Fiona Milner appointed Epichem General Manager 30/05/22 download Created with Sketch. 201.49KB Share PAA Resignation of Dr Richard Mollard 27/05/22 download Created with Sketch. 204.65KB Share PAA PharmAust Clinical Trials Update 24/05/22 PRICE SENSITIVE download Created with Sketch. 221.67KB Share PAA PharmAust receives $210k prepayment of forecast R&D rebate 17/05/22 PRICE SENSITIVE download Created with Sketch. 188.38KB Share PAA MPL tablets arrive in Melbourne for MND Clinical Trial 16/05/22 PRICE SENSITIVE download Created with Sketch. 219.07KB Share PAA PharmAust Expands Lymphoma Canine Trial to the USA 11/05/22 PRICE SENSITIVE download Created with Sketch. 222.32KB Share PAA Notification of cessation of securities - PAA 29/04/22 download Created with Sketch. 22.01KB Share PAA Appendix 4C and Quarterly Update 29/04/22 PRICE SENSITIVE download Created with Sketch. 860.4KB Share PAA PharmAust Receives $708k R&D Tax Incentive Refund 19/04/22 PRICE SENSITIVE download Created with Sketch. 187.5KB Share PAA PAA appoints trial manager & receives $200k from FightMND 08/04/22 PRICE SENSITIVE download Created with Sketch. 219.61KB Share PAA Notification of cessation of securities - PAA 31/03/22 download Created with Sketch. 21.49KB Share
(20min delay)
